Clin2
NCT06282107Possibly a fitNot yet recruiting

Testing a new approach for resistant hypertension

Resistant Hypertension

Part of Heart & circulation clinical trials.

This study tests a treatment called BiSAAE for people whose high blood pressure doesn't improve with three standard medicines. The goal is to see if it is safe and helps lower blood pressure better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
72 people
Ages
30 years to 65 years
Study type
Interventional

Who can take part

  • You are between 30 and 65 years old.
  • Your blood pressure is still high (≥140/90 in office or ≥130 average over 24 hours) despite taking three blood pressure medicines for at least 4 weeks.
  • You do not have a known cause for your high blood pressure (like kidney or adrenal gland disease).
  • You do not have advanced kidney disease, serious heart problems, or liver disease.
  • You are not pregnant, breastfeeding, or planning pregnancy, and you agree to use birth control if you could become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07081243Recruiting
A study on a procedure for hard-to-treat high blood pressure

This study looks at a procedure called renal denervation, which uses a device to calm overactive nerves in the kidneys that can drive high blood pressure. It is for people whose blood pressure stays high even with several medications, or who cannot tolerate blood pressure pills.

Shanghai, Shanghai Municipality
NCT07352969Not yet recruiting· Phase 2
Testing a new hypertension drug in mild to moderate patients

This trial tests a new medicine called IBI3016 for people with mild to moderate high blood pressure. It aims to find the right dose to safely lower blood pressure without other blood pressure medications.

Beijing, Beijing Municipality
NCT07556796Not yet recruiting· Phase 1
Testing IBI3016 for Mild to Moderate High Blood Pressure

This early-stage study tests a new medication called IBI3016 to help lower blood pressure in people with mild to moderate hypertension who haven't recently taken blood pressure medications. The goal is to see if this drug is safe and effective.

Beijing, Beijing Municipality
NCT06790927Not yet recruiting
Standardized blood pressure treatment study

This study tests a standard approach to lowering blood pressure in people whose blood pressure is not well controlled with current treatment. It may help find a more effective way to manage hypertension.

Shanghai, China
NCT07708441Not yet recruiting· Phase 2/Phase 3
Testing a new pill for hard-to-treat high blood pressure

This trial tests a new medication (HRS-1780) for people whose high blood pressure is not well controlled, even with current treatments. It may help lower blood pressure effectively.

Chongqing, Chongqing Municipality
NCT07373613Not yet recruiting· Phase 2
Testing new drugs for high blood pressure

This trial tests five new medications to see how well they lower blood pressure in people with essential hypertension (high blood pressure with no known cause). Participants will temporarily stop their current blood pressure medicine during the study.

Soeul

Hear when a new Resistant Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.